{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "21120604", "DateCompleted": {"Year": "2011", "Month": "04", "Day": "29"}, "DateRevised": {"Year": "2021", "Month": "10", "Day": "20"}, "Article": {"ArticleDate": [{"Year": "2010", "Month": "12", "Day": "01"}], "Language": ["eng"], "ELocationID": ["10.1007/s11064-010-0335-8"], "Journal": {"ISSN": "1573-6903", "JournalIssue": {"Volume": "36", "Issue": "2", "PubDate": {"Year": "2011", "Month": "Feb"}}, "Title": "Neurochemical research", "ISOAbbreviation": "Neurochem Res"}, "ArticleTitle": "4-hydroxybenzyl alcohol ameliorates cerebral injury in rats by antioxidant action.", "Pagination": {"StartPage": "339", "EndPage": "346", "MedlinePgn": "339-46"}, "Abstract": {"AbstractText": ["4-hydroxybenzyl alcohol (4-HBA), one of the phenolic constituents found in many herbal medicinal plants, exhibits beneficial effects in neurological disorders. In the present study, we evaluated 4-HBA's role in transient cerebral ischemia and its potential mechanism. Pre-treatment with 4-HBA (50,100 mg/kg) significantly reduced the cerebral infarct size and improved the neurological symptoms. Morphological examinations showed 4-HBA reduced the number of degenerated neurons. Oxidative stress was evaluated superoxide dismutase (SOD) activity and malondialdehyde (MDA) level. Anti-oxidative mechanisms were studied by Immunofluorescence staining and western immunoblot analysis. 4-HBA increased the expression of NAD(P)H: quinone oxidoreductase1 (NQO1) and ultimately inhibited oxidative stress. In addition, we evaluated the time course expression of NQO1, which was upregulated in the ischemic brain beginning at 1 h. Taken together, these results suggested that 4-HBA ameliorated cerebral injury in rats, This neuroprotective effect is likely related to its antioxidant activities."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pathology, Chongqing Medical University, Chongqing, People's Republic of China."}], "Identifier": [], "LastName": "Yu", "ForeName": "Shan-Shan", "Initials": "SS"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zhao", "ForeName": "Jing", "Initials": "J"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lei", "ForeName": "Shi-Peng", "Initials": "SP"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lin", "ForeName": "Xue-Mei", "Initials": "XM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Wang", "ForeName": "Ling-Li", "Initials": "LL"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zhao", "ForeName": "Yong", "Initials": "Y"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Neurochem Res", "NlmUniqueID": "7613461", "ISSNLinking": "0364-3190"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "0", "NameOfSubstance": "Benzyl Alcohols"}, {"RegistryNumber": "0", "NameOfSubstance": "Neuroprotective Agents"}, {"RegistryNumber": "1A3AH1FP1B", "NameOfSubstance": "4-hydroxybenzyl alcohol"}, {"RegistryNumber": "4Y8F71G49Q", "NameOfSubstance": "Malondialdehyde"}, {"RegistryNumber": "EC 1.15.1.1", "NameOfSubstance": "Superoxide Dismutase"}, {"RegistryNumber": "EC 1.6.5.2", "NameOfSubstance": "NAD(P)H Dehydrogenase (Quinone)"}, {"RegistryNumber": "EC 1.6.5.2", "NameOfSubstance": "NQO1 protein, rat"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Antioxidants"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Benzyl Alcohols"}, {"QualifierName": ["drug therapy", "pathology", "physiopathology"], "DescriptorName": "Brain Injuries"}, {"QualifierName": [], "DescriptorName": "Infarction, Middle Cerebral Artery"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["metabolism"], "DescriptorName": "Malondialdehyde"}, {"QualifierName": ["metabolism"], "DescriptorName": "NAD(P)H Dehydrogenase (Quinone)"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Neuroprotective Agents"}, {"QualifierName": [], "DescriptorName": "Neuropsychological Tests"}, {"QualifierName": ["drug effects"], "DescriptorName": "Oxidative Stress"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Sprague-Dawley"}, {"QualifierName": ["metabolism"], "DescriptorName": "Superoxide Dismutase"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Glia. 2009 Apr 15;57(6):645-56", "ArticleIdList": ["18942756"]}, {"Citation": "Phytother Res. 2007 Oct;21(10):960-4", "ArticleIdList": ["17604371"]}, {"Citation": "Stroke. 1989 Jan;20(1):84-91", "ArticleIdList": ["2643202"]}, {"Citation": "J Comp Neurol. 2004 Apr 5;471(3):289-97", "ArticleIdList": ["14991562"]}, {"Citation": "Chem Biol Interact. 2000 Dec 1;129(1-2):77-97", "ArticleIdList": ["11154736"]}, {"Citation": "Free Radic Biol Med. 2000 Aug;29(3-4):254-62", "ArticleIdList": ["11035254"]}, {"Citation": "Cancer Res. 2006 Dec 1;66(23):11416-23", "ArticleIdList": ["17145888"]}, {"Citation": "Neurochem Res. 2010 Mar;35(3):374-9", "ArticleIdList": ["19774461"]}, {"Citation": "Biol Pharm Bull. 2006 Feb;29(2):261-5", "ArticleIdList": ["16462028"]}, {"Citation": "J Pharmacol Exp Ther. 2007 Apr;321(1):249-56", "ArticleIdList": ["17259450"]}, {"Citation": "Brain Res. 2007 Nov 21;1181:130-41", "ArticleIdList": ["17945203"]}, {"Citation": "Biochim Biophys Acta. 2010 Jan;1802(1):92-9", "ArticleIdList": ["19751828"]}, {"Citation": "Chem Biol Interact. 2009 Dec 10;182(2-3):119-27", "ArticleIdList": ["19665455"]}, {"Citation": "Free Radic Biol Med. 2009 Jan 15;46(2):146-53", "ArticleIdList": ["18973804"]}, {"Citation": "Drug Metab Dispos. 2006 Jan;34(1):152-65", "ArticleIdList": ["16243960"]}, {"Citation": "J Biol Chem. 1992 Jun 5;267(16):11513-9", "ArticleIdList": ["1597478"]}, {"Citation": "Brain Res. 2007 Nov 14;1180:101-10", "ArticleIdList": ["17945201"]}, {"Citation": "Free Radic Biol Med. 2005 Aug 15;39(4):429-43", "ArticleIdList": ["16043015"]}, {"Citation": "Free Radic Biol Med. 2008 Nov 15;45(10):1375-83", "ArticleIdList": ["18824091"]}, {"Citation": "J Neurotrauma. 2000 Oct;17(10):871-90", "ArticleIdList": ["11063054"]}, {"Citation": "Biol Pharm Bull. 2005 Jun;28(6):1016-20", "ArticleIdList": ["15930737"]}, {"Citation": "Brain Res. 2010 Jan 13;1308:167-75", "ArticleIdList": ["19857470"]}, {"Citation": "Life Sci. 2000 Jan 14;66(8):709-23", "ArticleIdList": ["10680579"]}, {"Citation": "J Alzheimers Dis. 2008 Nov;15(3):473-93", "ArticleIdList": ["18997301"]}, {"Citation": "Neuropharmacology. 1992 Dec;31(12):1287-98", "ArticleIdList": ["1470304"]}, {"Citation": "Free Radic Biol Med. 2005 Aug 1;39(3):297-316", "ArticleIdList": ["15993329"]}, {"Citation": "Antioxid Redox Signal. 2010 Jan;12(1):125-69", "ArticleIdList": ["19624272"]}, {"Citation": "Annu Rev Nutr. 1996;16:33-50", "ArticleIdList": ["8839918"]}, {"Citation": "Drug Metab Rev. 2004 Oct;36(3-4):639-54", "ArticleIdList": ["15554240"]}, {"Citation": "Clin Chim Acta. 2010 Jun 3;411(11-12):840-5", "ArticleIdList": ["20193673"]}, {"Citation": "Neuropharmacology. 1993 Jul;32(7):659-69", "ArticleIdList": ["7689708"]}, {"Citation": "J Pharm Pharmacol. 2007 Sep;59(9):1235-40", "ArticleIdList": ["17883894"]}]}], "History": [{"Year": "2010", "Month": "11", "Day": "19"}, {"Year": "2010", "Month": "12", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2010", "Month": "12", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2011", "Month": "4", "Day": "30", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["21120604", "10.1007/s11064-010-0335-8"]}}], "PubmedBookArticle": []}